Schoolcraft, MI, United States of America

Gerald D Artman, Iii


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Gerald D Artman, III: Innovator in Metabolic Disease Treatments**

Introduction

Gerald D Artman, III, a noted inventor based in Schoolcraft, MI, has made significant contributions to the field of metabolic medicine. With a total of four patents to his name, Artman's work focuses on developing innovative therapies aimed at treating and preventing metabolic diseases, showcasing both creativity and scientific rigor.

Latest Patents

Artman’s most recent patents delve into novel compounds and methods related to metabolic disorders. His first patent outlines the development of PPAR-sparing compounds for the treatment of metabolic diseases. This invention pertains to hydroxamate compounds and pharmaceutical compositions that target metabolic inflammation, potentially assisting in conditions like diabetes, obesity, hypertension, and various neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.

His second latest patent focuses on innovative synthesis methods for thiazolidinedione compounds. This invention presents novel techniques for creating PPARγ sparing compounds that may also be effective in preventing and/or treating metabolic disorders such as diabetes and inflammation-related diseases.

Career Highlights

Artman is currently affiliated with Metabolic Solutions Development Company, LLC, where he continues to push the boundaries of medical research and development. His career is marked by a commitment to improving therapeutic options for patients suffering from complex metabolic conditions.

Collaborations

Throughout his career, Gerald D Artman, III has worked alongside esteemed colleagues such as Steven Paul Tanis and Timothy Parker. These collaborations have played a crucial role in fostering innovative research and driving forward the development of promising treatment options for metabolic diseases.

Conclusion

Gerald D Artman, III's work exemplifies the spirit of innovation in the medical field. With his significant patent portfolio and ongoing research endeavors at Metabolic Solutions Development Company, LLC, he is poised to make lasting contributions to the treatment of metabolic diseases, ultimately improving healthcare outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…